🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to evaluate efficacy and safety of regorafe...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-14
Trial ID
NCT01774344
Treatments Being Tested
60 patients of radiological, biopsy proven advanced HCC (Hepatocellular car...
Status
Completed
Location
Institute of Liver & Biliary Sciences
Start Date
2014-10-01
Trial ID
NCT02259647
The majority of patients with advanced NSCLC treated with standard platinum...
Status
Terminated
Location
University of Muenster, Dept. of Medicine, Hematology / Oncology
Start Date
2007-05
Trial ID
NCT00473486
Treatments Being Tested
RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
Royal Bournemouth Hospital
Start Date
2007-06
Trial ID
NCT00492258
Treatments Being Tested
To evaluate efficacy and safety of sorafenib versus placebo in the adjuvant...
Status
Completed
Location
Multiple Locations
Start Date
2008-08-15
Trial ID
NCT00692770
Treatments Being Tested
The purpose of this study is to evaluate Sorafenib and local microtherapy g...
Status
Completed
Location
University of Magdeburg
Start Date
2010-12
Trial ID
NCT01126645
Treatments Being Tested
The purpose of this study is to compare treatment with RAD001 plus best sup...
Status
Completed
Location
Highlands Oncology Group Dept of Highlands Oncology Grp
Start Date
2010-04
Trial ID
NCT01035229
Treatments Being Tested
The purpose of this study is to evaluate safety, efficacy (including qualit...
Status
Completed
Location
Multiple Locations
Start Date
2003-11
Trial ID
NCT00073307
Treatments Being Tested
The purpose of the study is: Find out if patients receiving sorafenib will ...
Status
Completed
Location
Multiple Locations
Start Date
2005-03
Trial ID
NCT00105443
Treatments Being Tested